World’s Largest Commercial Human Challenge Trials Unit Launched To Keep Up With Growing Demand

A UK-based CRO specializing in human challenge trials says there is a big shift in industry sentiment towards such studies. Companies targeting infectious diseases are now actively accommodating challenge trials in their development plans instead of needing persuasion.

Medicine Development Laboratory: Asian Female Scientist Using Microscope, Analyzes Petri Dish Sample. Big Pharmaceutical Lab with Specialists Conducting Biotechnology Research, Developing New Drugs.
Challenge trials can help generate efficacy data earlier • Source: Shutterstock

More and more companies developing treatments and vaccines for infectious diseases are seeing the value of incorporating human challenge trials in their development programs, given their potential to speed up product development, enable faster regulatory approval, and help with research and finance.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D